These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25062720)

  • 21. Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience.
    Acet-Öztürk NA; Ömer-Topçu D; Vurat Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Özkalemkaş F; Ener B; Ali R; Akalın H
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):33-43. PubMed ID: 37910269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
    Bergeron A; Belle A; Sulahian A; Lacroix C; Chevret S; Raffoux E; Arnulf B; Socié G; Ribaud P; Tazi A
    Chest; 2010 Feb; 137(2):410-5. PubMed ID: 19801584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
    Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic yield of bronchoscopic sampling in febrile neutropenic patients with pulmonary infiltrate and haematological disorders.
    Seneviratna A; O'Carroll M; Lewis CA; Milne D
    Intern Med J; 2012 May; 42(5):536-41. PubMed ID: 22150957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
    Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
    Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.
    Nguyen MH; Jaber R; Leather HL; Wingard JR; Staley B; Wheat LJ; Cline CL; Baz M; Rand KH; Clancy CJ
    J Clin Microbiol; 2007 Sep; 45(9):2787-92. PubMed ID: 17596367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis-A pilot study.
    Ajayababu A; Singh G; Meena VP; Upadhyay AD; Rana B; Sethi P; Prakash B; Singh A; Vyas S; Sinha S; Xess I; Wig N; Kabra SK; Ray A
    Mycoses; 2024 Jan; 67(1):e13695. PubMed ID: 38282361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of bronchoalveolar lavage samples in immunosuppressed patients with suspected pneumonia: analysis of a protocol.
    Vélez L; Correa LT; Maya MA; Mejía P; Ortega J; Bedoya V; Ortega H
    Respir Med; 2007 Oct; 101(10):2160-7. PubMed ID: 17629473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical usefulness of bronchoalveolar lavage in heart transplant recipients with suspected lower respiratory tract infection.
    Lehto JT; Anttila VJ; Lommi J; Nieminen MS; Harjula A; Taskinen E; Tukiainen P; Halme M
    J Heart Lung Transplant; 2004 May; 23(5):570-6. PubMed ID: 15135373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    Zhang XB; Chen GP; Lin QC; Lin X; Zhang HY; Wang JH
    Med Mycol; 2013 Oct; 51(7):688-95. PubMed ID: 23527739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients.
    Bhimji A; Bhaskaran A; Singer LG; Kumar D; Humar A; Pavan R; Lipton J; Kuruvilla J; Schuh A; Yee K; Minden MD; Schimmer A; Rotstein C; Keshavjee S; Mazzulli T; Husain S
    Clin Microbiol Infect; 2018 Jun; 24(6):640-645. PubMed ID: 28970160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients.
    Sakata KK; Klassen CL; Bollin KB; Grys TE; Slack JL; Wesselius LJ; Vikram HR
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28218980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of flexible bronchoscopy in the evaluation of pulmonary infiltrates in the hematopoietic stem cell transplant population -- a single center fourteen year experience.
    Gilbert CR; Lerner A; Baram M; Awsare BK
    Arch Bronconeumol; 2013 May; 49(5):189-95. PubMed ID: 23455477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection.
    Rawlings SA; Heldt S; Prattes J; Eigl S; Jenks JD; Flick H; Rabensteiner J; Prüller F; Wölfler A; Neumeister P; Strohmaier H; Krause R; Hoenigl M
    Front Immunol; 2019; 10():1798. PubMed ID: 31428097
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary infiltrates in patients with haematologic malignancies: transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis.
    Mulabecirovic A; Gaulhofer P; Auner HW; Popper H; Krause R; Hesse C; Sill H
    Ann Hematol; 2004 Jul; 83(7):420-2. PubMed ID: 15133629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.
    Maertens J; Maertens V; Theunissen K; Meersseman W; Meersseman P; Meers S; Verbeken E; Verhoef G; Van Eldere J; Lagrou K
    Clin Infect Dis; 2009 Dec; 49(11):1688-93. PubMed ID: 19886801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.